To Evaluate the Safety, Tolerability, and Immunogenicity of BNT162b2 Against COVID-19 in Healthy Pregnant Women 18 Years of Age and Older
Clinical trial NCT04754594 · COMPLETED
Trial details
- NCT number
- NCT04754594
- Sponsor
- BioNTech SE
- Status
- COMPLETED
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2021-02-16
- Primary completion
- 2022-07-15
- Enrollment
- 726
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.